Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne, A Laenen… - Acta …, 2022 - Taylor & Francis
Background Only a few recent phase III trials with targeted therapies or immune checkpoint
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne… - Acta oncologica …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Only a few recent phase III trials with targeted therapies or immune checkpoint
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study.
S Demasure, I Spriet, PR Debruyne… - Acta Oncologica …, 2021 - europepmc.org
Background Only a few recent phase III trials with targeted therapies or immune checkpoint
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
[DOC][DOC] Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne, A Laenen… - lirias.kuleuven.be
Background: Only a few recent phase III trials with targeted therapies or immune checkpoint
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study
S Demasure, I Spriet, PR Debruyne… - Acta …, 2022 - medicaljournalssweden.se
Background Only a few recent phase III trials with targeted therapies or immune checkpoint
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
inhibitors (ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an …
Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study.
S Demasure, I Spriet, PR Debruyne… - Acta …, 2022 - search.ebscohost.com
Only a few recent phase III trials with targeted therapies or immune checkpoint inhibitors
(ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an overall …
(ICIs) in metastatic clear-cell renal cell carcinoma (m-ccRCC) demonstrated an overall …